Myelin VC Overview
Myelin VC is a venture capital firm founded in 2019, focusing on early-stage technology investments across various industries. The firm partners with visionary founders to build innovative companies shaping the future. Myelin VC has made 26 investments, including notable exits such as Aura Biosciences, NUE Life Health, and Apryl.
Is Myelin VC the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Myelin VC, along with a list of other relevant VCs, is available on Hopohopo.io.
Myelin VC
Investment focus
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
€100,000 - €1,500,000
Contact information
Investment Partner
Federico Jack
Managing partner Levene Tax & Legal / Co-Founder
Cesar Levene
Co-Founder
Matias Nisenson
Managing Partner
Alec Oxenford
VP Finance & Operations
Milos Peluffo
How to approach funds like Myelin VC
When approaching Myelin VC, founders should highlight how their technology leverages unique insights or scientific advances to create defensible value. The team appreciates founders who can articulate a clear path from technical innovation to market impact, especially those with a deep understanding of their domain. Demonstrating early traction, a strong technical team, and a vision for scaling innovation will resonate well with their investment style.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
